Dow Up1.31% Nasdaq Up2.40%

IntelliPharmaCeutics International Inc. (IPCI)

-NasdaqCM
2.72 0.00(0.00%) 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingNov 30, 2013Nov 30, 2012Nov 30, 2011
Total Revenue 1,527   107   502  
Cost of Revenue -   -   -  
Gross Profit 1,527   107   502  
Operating Expenses
Research Development5,076  5,992  5,126  
Selling General and Administrative2,873  3,672  2,925  
Non Recurring -  107   -  
Others397  452  227  
Total Operating Expenses -  10,224   -  
Operating Income or Loss (6,819) (10,117) (7,777)
Income from Continuing Operations
Total Other Income/Expenses Net(4,246)4,044  5,338  
Earnings Before Interest And Taxes(11,065)(6,073)(2,439)
Interest Expense430  63  2,441  
Income Before Tax(11,495)(6,137)(4,880)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(11,495)(6,137)(4,880)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (11,495) (6,137) (4,880)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (11,495) (6,137) (4,880)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.